In this study, to predict prognosis of CSCC patients, we established a 5-immune-gene signature (including ICOS, ISG20, ANGPTL4, SBDS, and LTBR) in TCGA cohort and externally validated it in GEO cohorts. The gene discussed is SBDS; the disease is skin squamous cell carcinoma.